Cargando…

LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: The Liver Imaging Reporting and Data System (LI-RADS) for contrast-enhanced ultrasonography (CEUS) was invented to define suspected liver nodules based on their imaging characteristics. Among the categories of nodules of LI-RADS for CEUS, LR-5 is generally considered to be definitely mal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Hongyu, Cai, Yunshi, Zhang, Man, Huang, Libin, Bao, Wanying, Hu, Qibo, Chen, Xuan, Zhou, Lingyun, Ling, Wenwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929373/ https://www.ncbi.nlm.nih.gov/pubmed/36819240 http://dx.doi.org/10.21037/qims-22-591

Ejemplares similares

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

Deep learning LI-RADS grading system based on contrast enhanced multiphase MRI for differentiation between LR-3 and LR-4/LR-5 liver tumors
por: Wu, Yunan, et al.
Publicado: (2020)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI
por: Park, Seongkeun, et al.
Publicado: (2023)

Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience
por: Ciocalteu, Adriana, et al.
Publicado: (2021)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
por: Zhang, Haiping, et al.
Publicado: (2022)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm)
por: Ling, Wenwu, et al.
Publicado: (2018)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Diagnostic performance of ultrasonography-guided core-needle biopsy according to MRI LI-RADS diagnostic categories
por: Kim, Dong Wook, et al.
Publicado: (2021)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Benefits of Contrast-Enhanced Ultrasonography to the Differential Diagnosis of TI-RADS 4-5 Thyroid Nodules
por: Yu, Ping, et al.
Publicado: (2022)

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study
por: Ruan, Si-Min, et al.
Publicado: (2022)

Liver Imaging Reporting and Data System (LI-RADS) v2018: differential diagnostic value of ADC values for benign and malignant nodules with moderate probability (LR-3)
por: Chen, Xue, et al.
Publicado: (2023)

Retracted: Benefits of Contrast-Enhanced Ultrasonography to the Differential Diagnosis of TI-RADS 4-5 Thyroid Nodules
por: and Biomechanics, Applied Bionics
Publicado: (2023)

A Satisfactory Financial Position
Publicado: (1916)

Are Our Dental Organizations Satisfactory?
Publicado: (1894)

Diagnostic Value of Conventional Ultrasonography Combined with Contrast-Enhanced Ultrasonography in Thyroid Imaging Reporting and Data System (TI-RADS) 3 and 4 Thyroid Micronodules
por: Liu, Yingxian, et al.
Publicado: (2016)

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC
por: Wen, Rong, et al.
Publicado: (2023)

CEUS LI-RADS: a pictorial review
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2020)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Zhou, Hang, et al.
Publicado: (2021)

Practical and illustrated summary of updated BI-RADS for ultrasonography
por: Lee, Jiyon
Publicado: (2017)

[D-Leu(1)]MC-LR Has Lower PP1 Inhibitory Capability and Greater Toxic Potency than MC-LR in Animal and Plant Tissues
por: Sedan, Daniela, et al.
Publicado: (2020)

Unconventional Treatments for Vitiligo: Are They (Un) Satisfactory?
por: Gianfaldoni, Serena, et al.
Publicado: (2018)

Microcystin-LR (MC-LR) Triggers Inflammatory Responses in Macrophages
por: Su, Robin C., et al.
Publicado: (2021)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

Major and Ancillary Features According to LI-RADS in the Assessment of Combined Hepatocellular-cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2020)

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
por: Voizard, Nicolas, et al.
Publicado: (2019)

Cystic breast lesions by conventional ultrasonography: sonographic subtype-pathologic correlation and BI-RADS Assessment
por: Chen, Man, et al.
Publicado: (2014)

Accuracy of mammography and ultrasonography and their BI-RADS in detection of breast malignancy
por: Ghaemian, Naser, et al.
Publicado: (2021)

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma
por: Song, Yan, et al.
Publicado: (2023)

Towards satisfactory scattering amplitudes for dual fermions
por: Olive, D, et al.
Publicado: (1973)

Contrast-enhanced ultrasonography of the carotids
por: Rafailidis, Vasileios, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_osh6hhkripo8qki82cpl1igkr9